Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 5.31M 4.83M 4.45M 4.05M 7.6M 491M 7.99M 54.2M 21.54M 268M 19.91M 19.49M 842M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 5.39M 4.91M 4.52M 4.11M 7.71M 499M 8.11M 55.02M 21.87M 272M 20.21M 19.78M 855M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 5.31M | ||
| -2.49% | -3.76% | +50.31% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.20% | +89.22% | 58.56B | ||
| -2.37% | -2.22% | +22.87% | +82.31% | 54.19B | ||
| -2.19% | -6.15% | +11.92% | +108.08% | 44.66B | ||
| -1.89% | -7.28% | +13.22% | +19.74% | 40.51B | ||
| -0.93% | -0.47% | +19.73% | +43.75% | 36.27B | ||
| +1.11% | -6.44% | +130.68% | +641.83% | 34.89B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.26B | ||
| -2.17% | +16.65% | -29.21% | +474.05% | 31.01B | ||
| Average | -1.24% | -1.22% | +33.67% | +175.26% | 44B | |
| Weighted average by Cap. | -1.48% | -1.85% | +32.16% | +150.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 167K 154K 140K 262K 16.95M 275K 1.87M 743K 9.26M 687K 672K 29.05M | - |
| Net income | -7.23M -6.59M -6.07M -5.52M -10.36M -670M -10.89M -73.87M -29.36M -366M -27.13M -26.56M -1.15B | -2.89M -2.63M -2.43M -2.21M -4.14M -268M -4.35M -29.54M -11.74M -146M -10.85M -10.62M -459M |
| Net Debt | 478K 435K 401K 365K 685K 44.26M 719K 4.88M 1.94M 24.18M 1.79M 1.76M 75.87M | 80K 72.86K 67.14K 61.07K 115K 7.41M 120K 817K 325K 4.05M 300K 294K 12.7M |
Employees
-
















